Cargando…
Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics
Currently, most CNS tumors require tissue sampling to discern their molecular/genomic landscape. However, growing research has shown the powerful role imaging can play in non-invasively and accurately detecting the molecular signature of these tumors. The overarching theme of this review article is...
Autores principales: | Vagvala, Saivenkat, Guenette, Jeffrey P., Jaimes, Camilo, Huang, Raymond Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014574/ https://www.ncbi.nlm.nih.gov/pubmed/35436952 http://dx.doi.org/10.1186/s40644-022-00455-5 |
Ejemplares similares
-
KNL-1 Pathologic diagnosis of brain tumors in the molecular era
por: Hirose, Takanori
Publicado: (2020) -
Ex vivo ultrasonic samples of human brain tumors in the molecular era
por: Kirby, Alastair J, et al.
Publicado: (2020) -
Diagnostic yield of diffusion-weighted brain MR imaging in patients with cognitive impairment: Large cohort study with 3,298 patients
por: Kim, Minjae, et al.
Publicado: (2022) -
Molecular Imaging in Pediatric Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2019) -
Molecular Imaging in the Era of Personalized Medicine
por: Jung, Kyung-Ho, et al.
Publicado: (2015)